THE TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE, RESISTANT TO DIURETICS WITH NESIRITIDE: A CLINICAL CASE
Pranas Šerpytis Abstract Summary Despite modern treatment and diagnostics methods, patients suffering from acute decompensated heart failure 60 day mortality rate remains at 9,6%, furthermore, the hospitalization of patients with such diagnosis remains one of the most expensive. Nesiritide (recombinant human B-type natriuretic peptide) is a comparatively new drug for intravenous infusions, indicated for patients…